![WuXi Biologics (Cayman) Inc. Website](https://finchat.io/assets/logos/431763406.png)
WuXi Biologics (Cayman) Inc.
SEHK-2269
Basic
Market Cap
HK$44.84B
EV
HK$41.54B
Shares Out
4,151.52M
Revenue
CN¥17.03B
Employees
12,740
Margins
Gross
40.08%
EBITDA
28.93%
Operating
23.09%
Pre-Tax
24.5%
Net
19.96%
FCF
3.65%
Returns (5Yr Avg)
ROA
8.01%
ROTA
10.88%
ROE
10.63%
ROCE
8.85%
ROIC
9.47%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
HK$21.27
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
CN¥11.24B
Net Debt
-CN¥6,682.08M
Debt/Equity
0.1
EBIT/Interest
24.81
Growth (CAGR)
Rev 3Yr
44.79%
Rev 5Yr
46.38%
Rev 10Yr
—
Dil EPS 3Yr
24.54%
Dil EPS 5Yr
37.02%
Dil EPS 10Yr
—
Rev Fwd 2Yr
11.21%
EBITDA Fwd 2Yr
4.33%
EPS Fwd 2Yr
5.22%
EPS LT Growth Est
18.32%
Dividends
Yield
—
Payout
—
DPS
—
DPS Growth 3Yr
—
DPS Growth 5Yr
—
DPS Growth 10Yr
—
DPS Growth Fwd 2Yr
—
Select a metric from the list below to chart it
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
Dec '24 (E)
Dec '25 (E)
Dec '26 (E)